The Endocannabinoid System and Neurogenesis in Health and Disease
- 1 April 2007
- journal article
- research article
- Published by SAGE Publications in The Neuroscientist
- Vol. 13 (2) , 109-114
- https://doi.org/10.1177/1073858406296407
Abstract
The endocannabinoid system exerts an important neuromodulatory function in different brain areas and is also known to be involved in the regulation of neural cell fate. Thus, CB1 cannabinoid receptors are neuroprotective in different models of brain injury, and their expression is altered in various neurodegenerative diseases. Recent findings have demonstrated the presence of a functional endocannabinoid system in neural progenitor cells that participates in the regulation of cell proliferation and differentiation. In this Research Update, the authors address the experimental evidence regarding the regulatory role of cannabinoids in neurogenesis and analyze them in the context of those pathological disorders in which cannabinoid function and altered neuronal or glial generation is most relevant, for example, stroke and multiple sclerosis. NEUROSCIENTIST 13(2):109—114, 2007.Keywords
This publication has 28 references indexed in Scilit:
- A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington's disease human brainJournal of Chemical Neuroanatomy, 2006
- The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor CellsJournal of Neuroscience, 2006
- The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial CellsNeuron, 2006
- Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptorProceedings of the National Academy of Sciences, 2005
- Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptorsProceedings of the National Academy of Sciences, 2005
- The endocannabinoid system drives neural progenitor proliferationThe FASEB Journal, 2005
- Delayed onset of huntington′s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptorsNeuroscience, 2003
- Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212Journal of Clinical Investigation, 2003
- Therapeutic Action of Cannabinoids in a Murine Model of Multiple SclerosisJournal of Neuroscience, 2003
- The endogenous cannabinoid system and brain developmentPublished by Elsevier ,2000